Literature DB >> 22527102

Invasive breast carcinomas in Ghana: high frequency of high grade, basal-like histology and high EZH2 expression.

Judy Pang1, Kathy A Toy, Ken A Griffith, Baffour Awuah, Solomon Quayson, Lisa A Newman, Celina G Kleer.   

Abstract

Breast cancer in African-American women has a worse outcome than in Caucasian women. The ancestors of most African-American women come from West Africa, including Ghana. The Polycomb group protein EZH2 is a marker of poor outcome in breast cancers from Caucasian women. The histopathological features and biomarker expression of African breast cancers remain obscure. Here, we investigated a cohort of Ghanaian breast cancers to better define the prevalent tumor types and to test if EZH2 protein may identify aggressive tumors. A group of 169 breast tissues (100 invasive carcinomas and 69 benign) from women treated at Komfo Anoyke Teaching Hospital between 2006 and 2011 were histologically classified and investigated for EZH2 expression. EZH2 nuclear expression we defined as high or low following previously published criteria. Of the 100 invasive carcinomas, 89 % were ductal, 2 % were lobular, and 9 % were metaplastic. Basal-like pathological features were present in 30 % of the tumors. Of the invasive carcinomas, 7 % were grade 1, 41 % grade 2, and 52 % grade 3. EZH2 protein was overexpressed in invasive carcinomas compared to benign breast (p < 0.0001). In invasive carcinomas nuclear EZH2 overexpression was significantly associated with basal-like subtype (p = 0.03) and high histologic grade (p < 0.05). Cytoplasmic EZH2, which has not been previously reported, was present in 16 % of invasive carcinomas and it was associated with triple negative status (p = 0.02). Our results provide the first comprehensive histopathological study of this patient population and uncover the association of EZH2 with high grade and basal-like tumors. We provide the basis for further detailed investigations on this cohort to advance diagnosis and treatment of African and African-American women.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22527102      PMCID: PMC3906643          DOI: 10.1007/s10549-012-2055-z

Source DB:  PubMed          Journal:  Breast Cancer Res Treat        ISSN: 0167-6806            Impact factor:   4.872


  43 in total

1.  Characterization of interactions between the mammalian polycomb-group proteins Enx1/EZH2 and EED suggests the existence of different mammalian polycomb-group protein complexes.

Authors:  R G Sewalt; J van der Vlag; M J Gunster; K M Hamer; J L den Blaauwen; D P Satijn; T Hendrix; R van Driel; A P Otte
Journal:  Mol Cell Biol       Date:  1998-06       Impact factor: 4.272

2.  Phenotypic evaluation of the basal-like subtype of invasive breast carcinoma.

Authors:  Chad A Livasy; Gamze Karaca; Rita Nanda; Maria S Tretiakova; Olufunmilayo I Olopade; Dominic T Moore; Charles M Perou
Journal:  Mod Pathol       Date:  2006-02       Impact factor: 7.842

3.  African ancestry and higher prevalence of triple-negative breast cancer: findings from an international study.

Authors:  Azadeh Stark; Celina G Kleer; Iman Martin; Baffour Awuah; Anthony Nsiah-Asare; Valerie Takyi; Maria Braman; Solomon E Quayson; Richard Zarbo; Max Wicha; Lisa Newman
Journal:  Cancer       Date:  2010-11-01       Impact factor: 6.860

4.  Transcriptional repression mediated by the human polycomb-group protein EED involves histone deacetylation.

Authors:  J van der Vlag; A P Otte
Journal:  Nat Genet       Date:  1999-12       Impact factor: 38.330

5.  EZH2 expression is associated with high proliferation rate and aggressive tumor subgroups in cutaneous melanoma and cancers of the endometrium, prostate, and breast.

Authors:  Ingeborg M Bachmann; Ole J Halvorsen; Karin Collett; Ingunn M Stefansson; Oddbjørn Straume; Svein A Haukaas; Helga B Salvesen; Arie P Otte; Lars A Akslen
Journal:  J Clin Oncol       Date:  2005-12-05       Impact factor: 44.544

6.  Population differences in breast cancer: survey in indigenous African women reveals over-representation of triple-negative breast cancer.

Authors:  Dezheng Huo; Francis Ikpatt; Andrey Khramtsov; Jean-Marie Dangou; Rita Nanda; James Dignam; Bifeng Zhang; Tatyana Grushko; Chunling Zhang; Olayiwola Oluwasola; David Malaka; Sani Malami; Abayomi Odetunde; Adewumi O Adeoye; Festus Iyare; Adeyinka Falusi; Charles M Perou; Olufunmilayo I Olopade
Journal:  J Clin Oncol       Date:  2009-08-24       Impact factor: 44.544

Review 7.  Pattern of breast cancer among white-American, African-American, and nonimmigrant west-African women.

Authors:  T G Ijaduola; E B Smith
Journal:  J Natl Med Assoc       Date:  1998-09       Impact factor: 1.798

Review 8.  Triple negative breast carcinoma and the basal phenotype: from expression profiling to clinical practice.

Authors:  Leslie K Diaz; Vincent L Cryns; W Fraser Symmans; Nour Sneige
Journal:  Adv Anat Pathol       Date:  2007-11       Impact factor: 3.875

9.  Basal-like phenotype in a breast carcinoma case series from Sudan: prevalence and clinical/pathological correlations.

Authors:  Khalid Dafaallah Awadelkarim; Carmelo Arizzi; Elgizouli Omer Musa Elamin; Hussein M A Hamad; Pasquale De Blasio; Salwa O Mekki; Ihsan Osman; Ida Biunno; Nasr Eldin Elwali; Massimo Costanzo Barberis; Renato Mariani-Costantini
Journal:  Patholog Res Int       Date:  2011-01-09

10.  BRCA1-deficient mammary tumor cells are dependent on EZH2 expression and sensitive to Polycomb Repressive Complex 2-inhibitor 3-deazaneplanocin A.

Authors:  Julian Puppe; Rinske Drost; Xiaoling Liu; Simon A Joosse; Bastiaan Evers; Paulien Cornelissen-Steijger; Petra Nederlof; Qiang Yu; Jos Jonkers; Maarten van Lohuizen; Alexandra M Pietersen
Journal:  Breast Cancer Res       Date:  2009-08-26       Impact factor: 6.466

View more
  20 in total

Review 1.  Writing and rewriting the epigenetic code of cancer cells: from engineered proteins to small molecules.

Authors:  Pilar Blancafort; Jian Jin; Stephen Frye
Journal:  Mol Pharmacol       Date:  2012-11-13       Impact factor: 4.436

Review 2.  Matricellular CCN6 (WISP3) protein: a tumor suppressor for mammary metaplastic carcinomas.

Authors:  Mai N Tran; Celina G Kleer
Journal:  J Cell Commun Signal       Date:  2018-01-22       Impact factor: 5.782

Review 3.  Triple-negative breast cancer in African-American women: disparities versus biology.

Authors:  Eric C Dietze; Christopher Sistrunk; Gustavo Miranda-Carboni; Ruth O'Regan; Victoria L Seewaldt
Journal:  Nat Rev Cancer       Date:  2015-02-12       Impact factor: 60.716

Review 4.  Rewiring of the Endocrine Network in Triple-Negative Breast Cancer.

Authors:  Kaixuan Li; Dongjiang Zong; Jianrong Sun; Danxiang Chen; Minkai Ma; Liqun Jia
Journal:  Front Oncol       Date:  2022-06-30       Impact factor: 5.738

Review 5.  Noncanonical Functions of the Polycomb Group Protein EZH2 in Breast Cancer.

Authors:  Talha Anwar; Maria E Gonzalez; Celina G Kleer
Journal:  Am J Pathol       Date:  2021-02-06       Impact factor: 4.307

6.  The WNT10B Network Is Associated with Survival and Metastases in Chemoresistant Triple-Negative Breast Cancer.

Authors:  Ikbale El Ayachi; Iram Fatima; Peter Wend; Jackelyn A Alva-Ornelas; Stephanie Runke; William L Kuenzinger; Julio Silva; Wendy Silva; Joseph K Gray; Stephan Lehr; Hilaire C Barch; Raisa I Krutilina; Andrew C White; Robert Cardiff; Lisa D Yee; Lily Yang; Ruth M O'Regan; William E Lowry; Tiffany N Seagroves; Victoria Seewaldt; Susan A Krum; Gustavo A Miranda-Carboni
Journal:  Cancer Res       Date:  2018-12-18       Impact factor: 13.312

7.  A retrospective analysis of breast cancer subtype based on ER/PR and HER2 status in Ghanaian patients at the Korle Bu Teaching Hospital, Ghana.

Authors:  Bernard Seshie; Nii Armah Adu-Aryee; Florence Dedey; Benedict Calys-Tagoe; Joe-Nat Clegg-Lamptey
Journal:  BMC Clin Pathol       Date:  2015-07-09

8.  Loss of histone H4K20 trimethylation predicts poor prognosis in breast cancer and is associated with invasive activity.

Authors:  Yuhki Yokoyama; Ayaka Matsumoto; Miki Hieda; Yoshimi Shinchi; Eri Ogihara; Mai Hamada; Yu Nishioka; Hiroshi Kimura; Katsuhide Yoshidome; Masahiko Tsujimoto; Nariaki Matsuura
Journal:  Breast Cancer Res       Date:  2014-06-22       Impact factor: 6.466

9.  The prevalence of estrogen receptor-negative breast cancer in Ethiopia.

Authors:  Eva Johanna Kantelhardt; Assefa Mathewos; Abreha Aynalem; Tigeneh Wondemagegnehu; Ahmedin Jemal; Martina Vetter; Erdme Knauf; Anne Reeler; Solomon Bogale; Christoph Thomssen; Andreas Stang; Tufa Gemechu; Pietro Trocchi; Bekuretsion Yonas
Journal:  BMC Cancer       Date:  2014-11-29       Impact factor: 4.430

Review 10.  Therapeutic Strategies for Metastatic Triple-Negative Breast Cancers: From Negative to Positive.

Authors:  Dey Nandini; Aske Jennifer
Journal:  Pharmaceuticals (Basel)       Date:  2021-05-12
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.